カテゴリ： 世界, 医療/バイオ, QYResearch

ピロキシカムAPIの世界市場2023年：純度≧99%、純度≧99.5%

■ 英語タイトル：Global Piroxicam API Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA6524）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA6524
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：91
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[ピロキシカムAPIの世界市場2023年：純度≧99%、純度≧99.5%]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

本調査資料はピロキシカムAPIのグローバル市場について調査・分析し、世界のピロキシカムAPI市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（純度≧99%、純度≧99.5%）、用途別セグメント分析（錠剤、カプセル、注射剤、軟膏）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、SK Chemicals、Pfizer、Nostrum、Mylan、Teva、Viwit Pharmaceutical、Pidi Pharmaceutical、Maoxiang Pharmaceutical、Jumpcan Pharmaceutical、Changjiang Pharmaceutical、XinAn Pharmaceutical、Jiangxi Pharmaceuticalなどが含まれています。ピロキシカムAPIのグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、ピロキシカムAPI市場規模を算出する際に考慮しました。

・ピロキシカムAPI市場の概要
- 製品の定義
- ピロキシカムAPIの種類別セグメント
- 世界のピロキシカムAPI市場規模：タイプ別分析（純度≧99%、純度≧99.5%）
- ピロキシカムAPIの用途別セグメント
- 世界のピロキシカムAPI市場規模：用途別分析（錠剤、カプセル、注射剤、軟膏）
- 世界のピロキシカムAPI市場規模予測（2018年-2029年）
- ピロキシカムAPIの平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- ピロキシカムAPI市場の競争状況およびトレンド

・ピロキシカムAPIの地域別市場規模
- 北米のピロキシカムAPI市場規模（2018年-2029年）
- 米国のピロキシカムAPI市場規模（2018年-2029年）
- ヨーロッパのピロキシカムAPI市場規模（2018年-2029年）
- アジア太平洋のピロキシカムAPI市場規模（2018年-2029年）
- 中国のピロキシカムAPI市場規模（2018年-2029年）
- 日本のピロキシカムAPI市場規模（2018年-2029年）
- 韓国のピロキシカムAPI市場規模（2018年-2029年）
- インドのピロキシカムAPI市場規模（2018年-2029年）
- オーストラリアのピロキシカムAPI市場規模（2018年-2029年）
- 中南米のピロキシカムAPI市場規模（2018年-2029年）
- 中東・アフリカのピロキシカムAPI市場規模（2018年-2029年）

・種類別セグメント：純度≧99%、純度≧99.5%
- 世界のピロキシカムAPIのタイプ別販売量（2018年-2023年）
- 世界のピロキシカムAPIのタイプ別売上（2018年-2023年）
- 世界のピロキシカムAPIのタイプ別価格

・用途別セグメント：錠剤、カプセル、注射剤、軟膏
- 世界のピロキシカムAPIの用途別販売量（2018年-2023年）
- 世界のピロキシカムAPIの用途別売上（2018年-2023年）
- 世界のピロキシカムAPIの用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
SK Chemicals、Pfizer、Nostrum、Mylan、Teva、Viwit Pharmaceutical、Pidi Pharmaceutical、Maoxiang Pharmaceutical、Jumpcan Pharmaceutical、Changjiang Pharmaceutical、XinAn Pharmaceutical、Jiangxi Pharmaceutical

・産業チェーンと販売チャネルの分析
- ピロキシカムAPI産業チェーン分析
- ピロキシカムAPIの主要原材料
- ピロキシカムAPIの販売チャネル
- ピロキシカムAPIのディストリビューター
- ピロキシカムAPIの主要顧客

・ピロキシカムAPI市場ダイナミクス
- ピロキシカムAPIの業界動向
- ピロキシカムAPI市場の成長ドライバ、課題、阻害要因

・調査の結論

・調査手法と情報源

Highlights
The global Piroxicam API market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Piroxicam API is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Piroxicam API is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Piroxicam API include SK Chemicals, Pfizer, Nostrum, Mylan, Teva, Viwit Pharmaceutical, Pidi Pharmaceutical, Maoxiang Pharmaceutical and Jumpcan Pharmaceutical, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Piroxicam API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Piroxicam API.
The Piroxicam API market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Piroxicam API market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Piroxicam API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
SK Chemicals
Pfizer
Nostrum
Mylan
Teva
Viwit Pharmaceutical
Pidi Pharmaceutical
Maoxiang Pharmaceutical
Jumpcan Pharmaceutical
Changjiang Pharmaceutical
XinAn Pharmaceutical
Jiangxi Pharmaceutical
Segment by Type
Purity≥ 99%
Purity≥ 99.5%
Segment by Application
Tablets
Capsule
Injection
Ointment
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Piroxicam API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Piroxicam API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Piroxicam API Market Overview
1.1 Product Overview and Scope of Piroxicam API
1.2 Piroxicam API Segment by Type
1.2.1 Global Piroxicam API Market Value Comparison by Type (2023-2029)
1.2.2 Purity≥ 99%
1.2.3 Purity≥ 99.5%
1.3 Piroxicam API Segment by Application
1.3.1 Global Piroxicam API Market Value by Application: (2023-2029)
1.3.2 Tablets
1.3.3 Capsule
1.3.4 Injection
1.3.5 Ointment
1.4 Global Piroxicam API Market Size Estimates and Forecasts
1.4.1 Global Piroxicam API Revenue 2018-2029
1.4.2 Global Piroxicam API Sales 2018-2029
1.4.3 Global Piroxicam API Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Piroxicam API Market Competition by Manufacturers
2.1 Global Piroxicam API Sales Market Share by Manufacturers (2018-2023)
2.2 Global Piroxicam API Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Piroxicam API Average Price by Manufacturers (2018-2023)
2.4 Global Piroxicam API Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Piroxicam API, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Piroxicam API, Product Type & Application
2.7 Piroxicam API Market Competitive Situation and Trends
2.7.1 Piroxicam API Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Piroxicam API Players Market Share by Revenue
2.7.3 Global Piroxicam API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Piroxicam API Retrospective Market Scenario by Region
3.1 Global Piroxicam API Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Piroxicam API Global Piroxicam API Sales by Region: 2018-2029
3.2.1 Global Piroxicam API Sales by Region: 2018-2023
3.2.2 Global Piroxicam API Sales by Region: 2024-2029
3.3 Global Piroxicam API Global Piroxicam API Revenue by Region: 2018-2029
3.3.1 Global Piroxicam API Revenue by Region: 2018-2023
3.3.2 Global Piroxicam API Revenue by Region: 2024-2029
3.4 North America Piroxicam API Market Facts & Figures by Country
3.4.1 North America Piroxicam API Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Piroxicam API Sales by Country (2018-2029)
3.4.3 North America Piroxicam API Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Piroxicam API Market Facts & Figures by Country
3.5.1 Europe Piroxicam API Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Piroxicam API Sales by Country (2018-2029)
3.5.3 Europe Piroxicam API Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Piroxicam API Market Facts & Figures by Country
3.6.1 Asia Pacific Piroxicam API Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Piroxicam API Sales by Country (2018-2029)
3.6.3 Asia Pacific Piroxicam API Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Piroxicam API Market Facts & Figures by Country
3.7.1 Latin America Piroxicam API Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Piroxicam API Sales by Country (2018-2029)
3.7.3 Latin America Piroxicam API Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Piroxicam API Market Facts & Figures by Country
3.8.1 Middle East and Africa Piroxicam API Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Piroxicam API Sales by Country (2018-2029)
3.8.3 Middle East and Africa Piroxicam API Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Piroxicam API Sales by Type (2018-2029)
4.1.1 Global Piroxicam API Sales by Type (2018-2023)
4.1.2 Global Piroxicam API Sales by Type (2024-2029)
4.1.3 Global Piroxicam API Sales Market Share by Type (2018-2029)
4.2 Global Piroxicam API Revenue by Type (2018-2029)
4.2.1 Global Piroxicam API Revenue by Type (2018-2023)
4.2.2 Global Piroxicam API Revenue by Type (2024-2029)
4.2.3 Global Piroxicam API Revenue Market Share by Type (2018-2029)
4.3 Global Piroxicam API Price by Type (2018-2029)
5 Segment by Application
5.1 Global Piroxicam API Sales by Application (2018-2029)
5.1.1 Global Piroxicam API Sales by Application (2018-2023)
5.1.2 Global Piroxicam API Sales by Application (2024-2029)
5.1.3 Global Piroxicam API Sales Market Share by Application (2018-2029)
5.2 Global Piroxicam API Revenue by Application (2018-2029)
5.2.1 Global Piroxicam API Revenue by Application (2018-2023)
5.2.2 Global Piroxicam API Revenue by Application (2024-2029)
5.2.3 Global Piroxicam API Revenue Market Share by Application (2018-2029)
5.3 Global Piroxicam API Price by Application (2018-2029)
6 Key Companies Profiled
6.1 SK Chemicals
6.1.1 SK Chemicals Corporation Information
6.1.2 SK Chemicals Description and Business Overview
6.1.3 SK Chemicals Piroxicam API Sales, Revenue and Gross Margin (2018-2023)
6.1.4 SK Chemicals Piroxicam API Product Portfolio
6.1.5 SK Chemicals Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Piroxicam API Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Pfizer Piroxicam API Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Nostrum
6.3.1 Nostrum Corporation Information
6.3.2 Nostrum Description and Business Overview
6.3.3 Nostrum Piroxicam API Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Nostrum Piroxicam API Product Portfolio
6.3.5 Nostrum Recent Developments/Updates
6.4 Mylan
6.4.1 Mylan Corporation Information
6.4.2 Mylan Description and Business Overview
6.4.3 Mylan Piroxicam API Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Mylan Piroxicam API Product Portfolio
6.4.5 Mylan Recent Developments/Updates
6.5 Teva
6.5.1 Teva Corporation Information
6.5.2 Teva Description and Business Overview
6.5.3 Teva Piroxicam API Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Teva Piroxicam API Product Portfolio
6.5.5 Teva Recent Developments/Updates
6.6 Viwit Pharmaceutical
6.6.1 Viwit Pharmaceutical Corporation Information
6.6.2 Viwit Pharmaceutical Description and Business Overview
6.6.3 Viwit Pharmaceutical Piroxicam API Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Viwit Pharmaceutical Piroxicam API Product Portfolio
6.6.5 Viwit Pharmaceutical Recent Developments/Updates
6.7 Pidi Pharmaceutical
6.6.1 Pidi Pharmaceutical Corporation Information
6.6.2 Pidi Pharmaceutical Description and Business Overview
6.6.3 Pidi Pharmaceutical Piroxicam API Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Pidi Pharmaceutical Piroxicam API Product Portfolio
6.7.5 Pidi Pharmaceutical Recent Developments/Updates
6.8 Maoxiang Pharmaceutical
6.8.1 Maoxiang Pharmaceutical Corporation Information
6.8.2 Maoxiang Pharmaceutical Description and Business Overview
6.8.3 Maoxiang Pharmaceutical Piroxicam API Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Maoxiang Pharmaceutical Piroxicam API Product Portfolio
6.8.5 Maoxiang Pharmaceutical Recent Developments/Updates
6.9 Jumpcan Pharmaceutical
6.9.1 Jumpcan Pharmaceutical Corporation Information
6.9.2 Jumpcan Pharmaceutical Description and Business Overview
6.9.3 Jumpcan Pharmaceutical Piroxicam API Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Jumpcan Pharmaceutical Piroxicam API Product Portfolio
6.9.5 Jumpcan Pharmaceutical Recent Developments/Updates
6.10 Changjiang Pharmaceutical
6.10.1 Changjiang Pharmaceutical Corporation Information
6.10.2 Changjiang Pharmaceutical Description and Business Overview
6.10.3 Changjiang Pharmaceutical Piroxicam API Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Changjiang Pharmaceutical Piroxicam API Product Portfolio
6.10.5 Changjiang Pharmaceutical Recent Developments/Updates
6.11 XinAn Pharmaceutical
6.11.1 XinAn Pharmaceutical Corporation Information
6.11.2 XinAn Pharmaceutical Piroxicam API Description and Business Overview
6.11.3 XinAn Pharmaceutical Piroxicam API Sales, Revenue and Gross Margin (2018-2023)
6.11.4 XinAn Pharmaceutical Piroxicam API Product Portfolio
6.11.5 XinAn Pharmaceutical Recent Developments/Updates
6.12 Jiangxi Pharmaceutical
6.12.1 Jiangxi Pharmaceutical Corporation Information
6.12.2 Jiangxi Pharmaceutical Piroxicam API Description and Business Overview
6.12.3 Jiangxi Pharmaceutical Piroxicam API Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Jiangxi Pharmaceutical Piroxicam API Product Portfolio
6.12.5 Jiangxi Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Piroxicam API Industry Chain Analysis
7.2 Piroxicam API Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Piroxicam API Production Mode & Process
7.4 Piroxicam API Sales and Marketing
7.4.1 Piroxicam API Sales Channels
7.4.2 Piroxicam API Distributors
7.5 Piroxicam API Customers
8 Piroxicam API Market Dynamics
8.1 Piroxicam API Industry Trends
8.2 Piroxicam API Market Drivers
8.3 Piroxicam API Market Challenges
8.4 Piroxicam API Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables
Table 1. Global Piroxicam API Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Piroxicam API Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Piroxicam API Market Competitive Situation by Manufacturers in 2022
Table 4. Global Piroxicam API Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Piroxicam API Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Piroxicam API Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Piroxicam API Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Piroxicam API Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Piroxicam API, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Piroxicam API, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Piroxicam API, Product Type & Application
Table 12. Global Key Manufacturers of Piroxicam API, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Piroxicam API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Piroxicam API as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Piroxicam API Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Piroxicam API Sales by Region (2018-2023) & (K Units)
Table 18. Global Piroxicam API Sales Market Share by Region (2018-2023)
Table 19. Global Piroxicam API Sales by Region (2024-2029) & (K Units)
Table 20. Global Piroxicam API Sales Market Share by Region (2024-2029)
Table 21. Global Piroxicam API Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Piroxicam API Revenue Market Share by Region (2018-2023)
Table 23. Global Piroxicam API Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Piroxicam API Revenue Market Share by Region (2024-2029)
Table 25. North America Piroxicam API Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Piroxicam API Sales by Country (2018-2023) & (K Units)
Table 27. North America Piroxicam API Sales by Country (2024-2029) & (K Units)
Table 28. North America Piroxicam API Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Piroxicam API Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Piroxicam API Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Piroxicam API Sales by Country (2018-2023) & (K Units)
Table 32. Europe Piroxicam API Sales by Country (2024-2029) & (K Units)
Table 33. Europe Piroxicam API Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Piroxicam API Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Piroxicam API Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Piroxicam API Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Piroxicam API Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Piroxicam API Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Piroxicam API Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Piroxicam API Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Piroxicam API Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Piroxicam API Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Piroxicam API Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Piroxicam API Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Piroxicam API Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Piroxicam API Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Piroxicam API Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Piroxicam API Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Piroxicam API Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Piroxicam API Sales (K Units) by Type (2018-2023)
Table 51. Global Piroxicam API Sales (K Units) by Type (2024-2029)
Table 52. Global Piroxicam API Sales Market Share by Type (2018-2023)
Table 53. Global Piroxicam API Sales Market Share by Type (2024-2029)
Table 54. Global Piroxicam API Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Piroxicam API Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Piroxicam API Revenue Market Share by Type (2018-2023)
Table 57. Global Piroxicam API Revenue Market Share by Type (2024-2029)
Table 58. Global Piroxicam API Price (US$/Unit) by Type (2018-2023)
Table 59. Global Piroxicam API Price (US$/Unit) by Type (2024-2029)
Table 60. Global Piroxicam API Sales (K Units) by Application (2018-2023)
Table 61. Global Piroxicam API Sales (K Units) by Application (2024-2029)
Table 62. Global Piroxicam API Sales Market Share by Application (2018-2023)
Table 63. Global Piroxicam API Sales Market Share by Application (2024-2029)
Table 64. Global Piroxicam API Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Piroxicam API Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Piroxicam API Revenue Market Share by Application (2018-2023)
Table 67. Global Piroxicam API Revenue Market Share by Application (2024-2029)
Table 68. Global Piroxicam API Price (US$/Unit) by Application (2018-2023)
Table 69. Global Piroxicam API Price (US$/Unit) by Application (2024-2029)
Table 70. SK Chemicals Corporation Information
Table 71. SK Chemicals Description and Business Overview
Table 72. SK Chemicals Piroxicam API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. SK Chemicals Piroxicam API Product
Table 74. SK Chemicals Recent Developments/Updates
Table 75. Pfizer Corporation Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Piroxicam API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Pfizer Piroxicam API Product
Table 79. Pfizer Recent Developments/Updates
Table 80. Nostrum Corporation Information
Table 81. Nostrum Description and Business Overview
Table 82. Nostrum Piroxicam API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Nostrum Piroxicam API Product
Table 84. Nostrum Recent Developments/Updates
Table 85. Mylan Corporation Information
Table 86. Mylan Description and Business Overview
Table 87. Mylan Piroxicam API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Mylan Piroxicam API Product
Table 89. Mylan Recent Developments/Updates
Table 90. Teva Corporation Information
Table 91. Teva Description and Business Overview
Table 92. Teva Piroxicam API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Teva Piroxicam API Product
Table 94. Teva Recent Developments/Updates
Table 95. Viwit Pharmaceutical Corporation Information
Table 96. Viwit Pharmaceutical Description and Business Overview
Table 97. Viwit Pharmaceutical Piroxicam API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Viwit Pharmaceutical Piroxicam API Product
Table 99. Viwit Pharmaceutical Recent Developments/Updates
Table 100. Pidi Pharmaceutical Corporation Information
Table 101. Pidi Pharmaceutical Description and Business Overview
Table 102. Pidi Pharmaceutical Piroxicam API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Pidi Pharmaceutical Piroxicam API Product
Table 104. Pidi Pharmaceutical Recent Developments/Updates
Table 105. Maoxiang Pharmaceutical Corporation Information
Table 106. Maoxiang Pharmaceutical Description and Business Overview
Table 107. Maoxiang Pharmaceutical Piroxicam API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Maoxiang Pharmaceutical Piroxicam API Product
Table 109. Maoxiang Pharmaceutical Recent Developments/Updates
Table 110. Jumpcan Pharmaceutical Corporation Information
Table 111. Jumpcan Pharmaceutical Description and Business Overview
Table 112. Jumpcan Pharmaceutical Piroxicam API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Jumpcan Pharmaceutical Piroxicam API Product
Table 114. Jumpcan Pharmaceutical Recent Developments/Updates
Table 115. Changjiang Pharmaceutical Corporation Information
Table 116. Changjiang Pharmaceutical Description and Business Overview
Table 117. Changjiang Pharmaceutical Piroxicam API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Changjiang Pharmaceutical Piroxicam API Product
Table 119. Changjiang Pharmaceutical Recent Developments/Updates
Table 120. XinAn Pharmaceutical Corporation Information
Table 121. XinAn Pharmaceutical Description and Business Overview
Table 122. XinAn Pharmaceutical Piroxicam API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. XinAn Pharmaceutical Piroxicam API Product
Table 124. XinAn Pharmaceutical Recent Developments/Updates
Table 125. Jiangxi Pharmaceutical Corporation Information
Table 126. Jiangxi Pharmaceutical Description and Business Overview
Table 127. Jiangxi Pharmaceutical Piroxicam API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Jiangxi Pharmaceutical Piroxicam API Product
Table 129. Jiangxi Pharmaceutical Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Piroxicam API Distributors List
Table 133. Piroxicam API Customers List
Table 134. Piroxicam API Market Trends
Table 135. Piroxicam API Market Drivers
Table 136. Piroxicam API Market Challenges
Table 137. Piroxicam API Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Piroxicam API
Figure 2. Global Piroxicam API Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Piroxicam API Market Share by Type in 2022 & 2029
Figure 4. Purity≥ 99% Product Picture
Figure 5. Purity≥ 99.5% Product Picture
Figure 6. Global Piroxicam API Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Piroxicam API Market Share by Application in 2022 & 2029
Figure 8. Tablets
Figure 9. Capsule
Figure 10. Injection
Figure 11. Ointment
Figure 12. Global Piroxicam API Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Piroxicam API Market Size (2018-2029) & (US$ Million)
Figure 14. Global Piroxicam API Sales (2018-2029) & (K Units)
Figure 15. Global Piroxicam API Average Price (US$/Unit) & (2018-2029)
Figure 16. Piroxicam API Report Years Considered
Figure 17. Piroxicam API Sales Share by Manufacturers in 2022
Figure 18. Global Piroxicam API Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Piroxicam API Players: Market Share by Revenue in 2022
Figure 20. Piroxicam API Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 21. Global Piroxicam API Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 22. North America Piroxicam API Sales Market Share by Country (2018-2029)
Figure 23. North America Piroxicam API Revenue Market Share by Country (2018-2029)
Figure 24. United States Piroxicam API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada Piroxicam API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe Piroxicam API Sales Market Share by Country (2018-2029)
Figure 27. Europe Piroxicam API Revenue Market Share by Country (2018-2029)
Figure 28. Germany Piroxicam API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. France Piroxicam API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. U.K. Piroxicam API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Italy Piroxicam API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Russia Piroxicam API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Asia Pacific Piroxicam API Sales Market Share by Region (2018-2029)
Figure 34. Asia Pacific Piroxicam API Revenue Market Share by Region (2018-2029)
Figure 35. China Piroxicam API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Japan Piroxicam API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. South Korea Piroxicam API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. India Piroxicam API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Australia Piroxicam API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. China Taiwan Piroxicam API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Indonesia Piroxicam API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Thailand Piroxicam API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Malaysia Piroxicam API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Latin America Piroxicam API Sales Market Share by Country (2018-2029)
Figure 45. Latin America Piroxicam API Revenue Market Share by Country (2018-2029)
Figure 46. Mexico Piroxicam API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Brazil Piroxicam API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Argentina Piroxicam API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Colombia Piroxicam API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Middle East & Africa Piroxicam API Sales Market Share by Country (2018-2029)
Figure 51. Middle East & Africa Piroxicam API Revenue Market Share by Country (2018-2029)
Figure 52. Turkey Piroxicam API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Piroxicam API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. UAE Piroxicam API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Global Sales Market Share of Piroxicam API by Type (2018-2029)
Figure 56. Global Revenue Market Share of Piroxicam API by Type (2018-2029)
Figure 57. Global Piroxicam API Price (US$/Unit) by Type (2018-2029)
Figure 58. Global Sales Market Share of Piroxicam API by Application (2018-2029)
Figure 59. Global Revenue Market Share of Piroxicam API by Application (2018-2029)
Figure 60. Global Piroxicam API Price (US$/Unit) by Application (2018-2029)
Figure 61. Piroxicam API Value Chain
Figure 62. Piroxicam API Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • カプトプリル錠の世界市場2023年：25mg、12.5mg
  • メトトレキサート錠の世界市場2023年：2mg、2.5mg、10mg、その他
  • レボドパ＆ベンセラジド塩酸塩の世界市場2023年：カプセル、錠剤、顆粒
  • テトラサイクリン系抗生物質の世界市場2023年：クロルテトラサイクリン、オキシテトラサイクリン、テトラサイクリン、メチルオキシテトラサイクリン、ドキシサイクリン、ミノサイクリン
  • グリコピロレート錠の世界市場2023年：0.5mg、1mg、2mg
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA6524 )"ピロキシカムAPIの世界市場2023年：純度≧99%、純度≧99.5%" (英文：Global Piroxicam API Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。